CableFinder, the industry-standard platform for advanced quoting and contracting with major technology service distributors (TSDs) and their partners, today announced a partnership with Lightpath that ...
A closely watched clinical trial testing a new two-drug combination against metastatic uveal melanoma, the deadliest form of ...
No one wants to think about their healthy, vibrant pup growing old. However, your pet will hopefully one day reach a more ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company, today announced plans to issue a joint IDEAYA ...
The MarketWatch News Department was not involved in the creation of this content.-- First patient dosed in France, expanding the DOMISOL study beyond Australia -- DT--7012 is bein ...